Neuroblastoma is a pediatric cancer entity characterized by a low mutational burden, but a high frequency of chromosomal copy number alterations (CNAs).
I provide wet lab assistance for the in vitro functional characterization of novel candidate tumor suppressor genes and dependency genes in this disease of which the expression levels are altered through these CNAs.
I obtained a Master Degree in Biomedical Sciences (UGent-2021).
I started working in the Center for Medical genetics in April 2022 as a full time technician.
I have experience in RT-qPCR, cell culture, functional cell assays, in vitro drug testing, and protein assays.